25 Benchmark Types

•

1 recomendación•1,115 vistas

Best Practices

In our 20 years in business, we've developed over 25 benchmark types. Here are a few of them!

DIFFERENT BENCHMARKS YIELD DIFFERENT INSIGHTS
Benchmarking is #1 Most Used Global Mgt. Tool
(Source: Bain & Co. 2011 Mgt. Tools & Trends Census)
• 1) STRATEGY 2) STRUCTURE 3) LEADERSHIP

• 4) COST 5) INVESTMENT 6) BUSINESS ECONOMICS

• 7) STAFFING 8) SKILLS 9) TALENT 10) SOURCING

• 11) SERVICES 12) ACTIVITIES 13) IMPACT ANALYSIS

• 14) TECHNOLOGY 15) INNOVATION 16) FUTURE TRENDS

• 17) QUALITY 18) CYCLE TIMES 19) YIELDS 20) PRODUCTIVITY

• 21) BEST PRACTICE INSIGHTS 22) PROCESS EXCELLENCE

• 23) ANALOGS 24) LAUNCH PLANNING 25) LIFECYCLE INSIGHTS
Marty Daniel, Client Services Manager
(919) 767‐9223 direct
mdaniel@best‐in‐class.com

Más contenido relacionado

Más de Best Practices

The new product planning function within bio-pharmaceutical companies is tasked with the challenging role of delivering potential new products in shorter time frames and minimum development costs. This Best Practices, LLC benchmarking report examines the role and impact of new product planning function on product commercialization. In particular, it examines the impact of structure, resources and activities of new product planning groups on product commercialization. Download Full Report: http://bit.ly/2e8ErMD

Drive Growth and Profitability Through Strategic Pharmaceutical New Product P...

Best Practices

Medical information groups within bio-pharmaceutical companies play a vital role in the management of publications and product inquiries during the commercialization of drugs. However, recent regulatory changes in the industry have made it imperative for the Medical Affairs function to align its medical information activities with compliance requirements. This Best Practices, LLC report establishes benchmarks on the critical requirements to create strong medical information groups. In particular, this report identifies best practices in internal collaboration, alignment of information activities with compliance requirements and the structure, leadership and resource levels required to develop best-in-class medical information groups. Download Full Report: http://bit.ly/2ewac07

Best-in-Class Strategies to Develop Effective Medical Information Groups

Best Practices

The current structure of medical education emphasizes pedagogy related to the physician-patient relationship, and thus advocacy opportunities at this level. Patient and professional Advocacy Groups are important to the process of educating the marketplace on new therapies. Strong relationships with advocacy groups are important for educating the public on socially-sensitive conditions and treatment options. Best Practices, LLC's study identifies effective practices in patient advocacy group collaboration and relationship management. This study also examines ideal structures and skill sets for pharma groups that deal with advocacy groups and emerging trends and challenges in patient advocacy. Download Full Report: http://bit.ly/2evZ0AE

Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...

Best Practices

The Medical Affairs function plays an important role in health outcomes (HO) information exchange between bio-pharmaceutical organizations and key external stakeholders. Development of robust health outcomes capabilities within Medical Affairs function requires an increase in the function’s involvement with health outcomes groups, development of field-based health outcomes capabilities, customization of health outcomes data as per stakeholders’ needs, and building real world data capabilities to generate and utilize health outcomes information. This benchmarking research from Best Practices, LLC is designed to assist companies focused on oncology therapies find better ways to develop effective health outcomes groups. It provides current data and best practices from Medical Affairs leaders with an oncology focus at leading bio-pharmaceutical companies. Download Full Report: http://bit.ly/2e3sl9Q

Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...

Best Practices

With the shift toward evidence-based medicine and value-based pricing, many bio-pharmaceutical companies are transitioning their Health Economics and Outcomes Research (HEOR) function away from the Commercial organization to Medical Affairs. This has some major implications towards the interactions with key stakeholders, the way interactions are documented and the skill sets & activities that may be required. Development of strong health outcomes capabilities within Medical Affairs organizations requires an increase in that function’s involvement with health outcomes groups, development of field-based health outcomes capabilities, customization of health outcomes data by stakeholders and building real world data capabilities to generate and utilize health outcomes information. Best Practices, LLC undertook this study to identify strategies to increase MA’s role in Health Outcomes data generation and utilization. Specifically, the study highlights the role of Medical Affairs function in HO activities, industry drivers and resource levels for HO groups, challenges of MA’s involvement in HO activities and strategies for effective HO data communication and utilization. Download Full Report: http://bit.ly/2dGFAbz

Strategies to Increase Medical Affairs' Role in Health Outcomes Data Generati...

Best Practices

Bio-pharmaceutical organizations have long relied on medical education programs to provide latest medical knowledge to physicians and other health care professionals. However, recent compliance rules and regulations have tempered the sponsorship of some medical education programs by bio-pharmaceutical companies, as well as some third-party providers of such services. Best Practices, LLC, undertook benchmarking research to probe emerging medical education trends at top bio-pharmaceutical companies. In particular, this research provides benchmarks on the proper size, structure, activities performed, staffing, and investment for the Medical Education function. Download Full Report: http://bit.ly/2cf5PYb

Benchmarking Bio-Pharmaceutical Medical Education Programs: Structures, Resou...

Best Practices

Medical education programs play an important role in informing health care professionals about the safe and effective use of medical devices. To probe emerging medical education trends in the device sector, Best Practices, LLC undertook benchmarking research. In particular, this study provides benchmarks on the proper size, structure, funding channels, staffing and investment for medical education groups. Download Full Report: http://bit.ly/2bY2NZ8

Emerging Medical Education Trends in the Medical Device Industry: Benchmarks ...

Best Practices

Delays in the launch and execution of critical market research projects can slow down the decision-making process, resulting in missed opportunities and increased costs. Therefore, it is absolutely critical for bio-pharmaceutical companies to develop a tactical approach to expedite the market research approval process for quicker and more meaningful insights. According to recent research by Best Practices, LLC, nearly three-quarters of the benchmarked study participants use review cycle time as a metric for determining if the market research approval process is functioning at an acceptable level. One tip that participants gave on how to control processes and to ensure high performance is to create checklists. Begin with checklists in pinch points that are most problematic, and then extend to entire process and operations. This report will help leaders to gain critical insights they need to compete successfully in a fast-changing market. Download Full Report: http://bit.ly/2bfAhOc

Faster Market Research Approvals

Best Practices

Continuing Medical Education (CME) programs serve to maintain, develop or enhance the skills, knowledge and professional performance & relationships that a physician uses to provide services to patients, public and the profession. However, recent compliance and transparency rules have tempered the sponsorship of some medical education programs by bio-pharmaceutical companies as well as some third-party providers of such services. Critics such as Morris and Taitsman also prefer that the medical profession eliminate commercial support for CME. Best Practices, LLC conducted this study to inform those who lead medical education programs at large bio-pharmaceutical companies about the proper size, resourcing and structure for the medical education function. The study looks into emerging Medical Education trends at medical device and pharmaceutical organizations regarding funding and program types. Download Full Report: http://bit.ly/2bAUm6U

Benchmarking Professional Medical Education Excellence Structures

Best Practices

Given the stringent regulatory requirements in the health care industry, it is important for bio-pharmal companies to develop innovative Risk Evaluation and Mitigation Strategies (REMS) plans during the commercialization of certain products to ensure an acceptable risk-to-benefit ratio. This benchmark study published by Best Practices, LLC examines how companies develop and execute successful Risk Evaluation and Mitigation Strategies (REMS) plans for newly-approved drugs in the U.S. market. This study can help bio-pharma companies in creating successful REMS programs. Download Full Report: http://bit.ly/2aOt5Id

Models & Trends in REMS Program Success

Best Practices

Bio-Pharma companies can no longer afford to rely solely on past experiences when budgeting for a new product launch in today's fast-changing, highly competitive market. This comprehensive benchmark study by Best Practices, LLC investigates current costs as well as budget and staffing allocations required for a successful drug launch. This study can help bio-pharma leaders to develop competitive launch and pre-launch activity budgets to ensure successful U.S. market entry for new products. Download Full Report: http://bit.ly/2aMYron

Budget Allocation for a Successful Bio-Pharma Product Launch

Best Practices

Optimizing the resource and staffing levels at medical device companies enables Regulatory Affairs leaders to prioritize roles and responsibilities, thereby driving organizational growth. Research & Consulting leader, Best Practices, LLC engaged Regulatory Affairs leaders at 32 leading medical device companies through a benchmarking survey to capture insights regarding current and future trends shaping the Regulatory Affairs function. This study delivers benchmarks around the critical drivers of regulatory performance excellence at medical device companies. Download Full Report: http://bit.ly/2asHvQh

Driving Performance Excellence in the Regulatory Affairs Function at Medical ...

Best Practices

Disease Awareness Program Excellence: Structure, Timing, Activities & Investm...

Best Practices

Libraries are custodians of invaluable information. The study - Library Services Benchmarks 2016: Corporate Library Services in the Pharmaceutical Industry published by Best Practices, LLC examines the trends and staffing benchmarks such as library staff per potential and actual users across companies providing access to library services across the bio-pharmaceutical space. This study looks into staff with formal education level and the number of staff inside and outside the library who provide library services. This study can be used by bio-pharmaceutical companies to improve upon existing library services and staffing. Download Full Report: http://bit.ly/29QZcbM

Library Services Benchmarks - Using Corporate Library Services in Pharma

Best Practices

Rising competition and access restrictions in the bio-pharmaceutical industry have made it critical for companies to prepare and measure the performance of their District Sales Managers (DMs) who oversee launch-related activities in the field. Best Practices, LLC engaged 20 sales leaders from bio-pharmaceutical companies to establish benchmarks around the training and accountability of District Sales Managers at launch. Insights from this study will serve as a reference point for companies to evaluate their launch training programs for the sales force against industry benchmarks. Download Full Report: http://bit.ly/29Gq68L

Effective Launch Training Practices for District Sales Managers: Optimize Per...

Best Practices

In order to develop an effective global branding program for new bio-pharmaceutical products, it is important to ensure brand consistency across all functions and geographies. Best Practices, LLC undertook research to gather benchmarks on key aspects of the global branding process, including activities, timing, positioning, key message development, regional alignment, agency utilization & cost and the tradename process. Download Full Report: http://bit.ly/2a1XqUV

Best Practices in Creating Global Brand for New Products and Ensuring Alignme...

Best Practices

Biopharmaceutical and medical device companies rely on advisory board for strategic inputs and guidance on various business aspects. However, successful advisory board management requires optimum investment in resources and operations. It is also important that the biopharmaceutical and medical device executives ensure quality of meetings and dialogue with advisory boards is excellent for maximum ROI. This research from Best Practices, LLC showcase the best practices in advisory board management at mid-sized biopharmaceutical and medical device companies. It also highlights the top challenges, winning strategies and best practices for conducting advisory boards.

Benchmarking Advisory Board Management at Mid-Sized Pharmaceutical & Medical ...

Best Practices

This presentation gives an insight into the membership benefits of Best Practices, LLC’s Medical Affairs Consortium. It also highlights some of the key benchmarks and best practices that emerged from Medical Affairs Consortium. The Medical Affairs Consortium at Best Practices, LLC provides a dedicated platform to Medical Affairs Leaders to discuss top challenges, develop action oriented solutions, share best practices & lessons learned and explore current and future trends with regards to the Medical Affairs function and its interactions with other critical functions. Topics for the Medical Affairs Consortium are usually determined by member requests. The Medical Affairs Consortium addresses three key areas: • Building Strong Medical Affairs Capabilities • Medical Affairs Launch Support Excellence • Medical Affairs’ Critical Role in Health Economics & Outcomes Research

Medical Affairs Consortium

Best Practices

Pharmaceutical advisory boards provide strategic inputs and guidance to organizations on various business aspects. However, successful advisory board management requires optimum investment in resources and operations. To maximize the return on investment it is important for pharmaceutical and medical device professionals to ensure that the quality of meetings and dialogue with advisory boards is excellent. This research from Best Practices, LLC is designed for pharmaceutical and biotech executives seeking ways to best utilize the knowledge of advisory boards. Research findings provide benchmarks on the appropriate structure for various types of advisory boards, selection of advisory board participants, advisory board operational and resource benchmarks.

Benchmarking Advisory Board Management At Large Pharmaceutical And Medical De...

Best Practices

Competitive Assessments and Clinical Landscape Assessments are crucial to the success of new products in the pharmaceutical industry. In order to inform busy executives quickly and effectively, market intelligence and analytics leaders must develop briefing templates that are clear, concise, and impactful. This study identifies winning strategies for effectively informing senior leaders through Competitive Landscape Summaries and Clinical Development Profile Maps. The research will help executives to understand what the important elements to include are, and what are the best formats for two critical healthcare briefing templates: : 1) the Competitive Landscape Summary Map and 2) the Development Landscape Profile Map (often described as the Data Disclosure or Clinical Trials Progress Summary). Read more at: http://www.best-in-class.com/bestp/domrep.nsf/products/developing-high-impact-communication-forms-to-brief-senior-leaders-optimizing-competitive-assessment-data-disclosure-summaries?OpenDocument

Developing High-Impact Communication Forms to Brief Senior Leaders: Optimizin...

Best Practices

Más de Best Practices (20)

Drive Growth and Profitability Through Strategic Pharmaceutical New Product P...

Best-in-Class Strategies to Develop Effective Medical Information Groups

Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...

Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...

Strategies to Increase Medical Affairs' Role in Health Outcomes Data Generati...

Benchmarking Bio-Pharmaceutical Medical Education Programs: Structures, Resou...

Emerging Medical Education Trends in the Medical Device Industry: Benchmarks ...

Faster Market Research Approvals

Benchmarking Professional Medical Education Excellence Structures

Models & Trends in REMS Program Success

Budget Allocation for a Successful Bio-Pharma Product Launch

Driving Performance Excellence in the Regulatory Affairs Function at Medical ...

Disease Awareness Program Excellence: Structure, Timing, Activities & Investm...

Library Services Benchmarks - Using Corporate Library Services in Pharma

Effective Launch Training Practices for District Sales Managers: Optimize Per...

Best Practices in Creating Global Brand for New Products and Ensuring Alignme...

Benchmarking Advisory Board Management at Mid-Sized Pharmaceutical & Medical ...

Medical Affairs Consortium

Benchmarking Advisory Board Management At Large Pharmaceutical And Medical De...

Developing High-Impact Communication Forms to Brief Senior Leaders: Optimizin...